EUVIMED · CrossrefJournal
Arthritis Research & Therapy
ISSN 1478-6362 · Springer Science and Business Media LLC
Latest articles
Visualizing periarticular inflammation of the shoulder and pelvic girdles in polymyalgia rheumatica with [68Ga]Ga-DOTA-Siglec-9 PET/CT
Clinical utility of radial and ulnar artery diameter measurement using vascular ultrasonography in patients with systemic sclerosis
Transcriptional profiling reveals an EBI3-high LAMP3⁺CCR7⁺ dendritic cell subset in rheumatoid arthritis synovial fluid
Single-cell profiling of PBMCs reveals distinct immune signatures associated with methotrexate response in rheumatoid arthritis
Very early pulmonary function decline in systemic sclerosis: longitudinal evidence from the STRIKE and EUSTAR VEDOSS cohorts
Obesity and fibromyalgia are associated with a difficult-to-manage psoriatic arthritis phenotype and adverse long-term outcomes
Integrating network toxicology, interpretable machine learning, and molecular docking to unravel key molecular networks in diethyl phthalate-related rheumatoid arthritis
Immune checkpoint inhibitors in patients with rheumatoid arthritis: a matched cohort study of immune-related adverse events and survival
Confirmation of anti-TERF1 autoantibodies in systemic sclerosis and fibrotic lung disease using a novel particle-based immunoassay
Pain management and its variation by deprivation in patients with inflammatory arthritis: the PAIN PATH surveys
Compartment-specific associations between knee joint space width and clinical outcomes
An in-depth in vitro study decodes hapln1-induced proinflammatory m1 macrophage polarization via FLSs- MΦ crosstalk: integrating bioinformatic analysis to functional study
Depth-specific characterization of bone microarchitecture in the femoral head: implications for osteoarthritis and osteoporosis research
Tofacitinib and esophageal-related manifestations in systemic sclerosis: a retrospective real-world cohort focused on lower esophageal sphincter pressure changes
Plexin C1 promotes synovial aggression and inflammation through STAT3-dependent Cyclin D1 activation in rheumatoid arthritis
Endothelial-derived FABP4 promotes EGFR activation in fibroblast-like synoviocytes during osteoarthritis synovial ferroptosis
HLA-B*27-associated arthritis across the ages – bridging the gap
Fenofibrate restores cartilage homeostasis and attenuates ferroptosis-associated injury in osteoarthritis
Correction: Sjögren’s patient subgroups identified through whole genome DNA methylation profiling
Fc N-glycosylation heterogeneity of anti-MDA5 IgG is associated with interstitial lung disease severity via regulating FcγR/C1q signaling in MDA5 + dermatomyositis: a cross‑sectional study
Diagnostic value of anti-carbamylated protein combined with Anti-RA33 antibodies in seronegative rheumatoid arthritis: a retrospective cohort study
Effect of apremilast on entheseal bone damage in psoriasis patients at risk of developing psoriatic arthritis - data from the prospective, interventional EPOS study
Inflammation-driven bone erosion and reactive remodeling in experimental arthritis revealed by cortical bone surface analysis
Organ damage progression in antiphospholipid antibody carriers: a longitudinal cohort study
Effectiveness, safety and persistence of filgotinib in rheumatoid arthritis with a specific focus on difficult-to-treat patients: results from a multicentre observational study
Gaps in care for hydroxychloroquine retinopathy screening in patients with systemic lupus erythematosus or rheumatoid arthritis: a population-based cohort study
Integrative proteomic and machine learning strategies identify key biomarkers associated with response to JAK inhibitor in rheumatoid arthritis
Serum mass spectrometry unveil the heterogeneity of rheumatoid arthritis and reveals insights into complement pathways and IGHV as potential prognostic markers
Patterns of the gut microbiota and metabolome as potential biomarkers associated with influenza vaccine immunogenicity in systemic lupus erythematosus: a cross-sectional observational pilot study
Correction: Clinical and MRI remission in axial spondyloarthritis: one-year outcomes and predictors from the TRACE treat-to-target study with secukinumab
EUVIMED